In cases of adrenocortical carcinoma, hepatocellular carcinoma, bladder urothelial carcinoma, endometrial carcinoma, pheochromocytoma and uveal melanoma, high mRNA levels of MBOAT2 can make a poor prognosis more likely [19]. Here, MBOAT2 is linked to hepatocellular carcinoma.